Jenna Aronson, PhD

Jenna is a Principal at Two Bear Capital where she sources, diligences, and leads investments in innovative life sciences therapeutics companies. She serves as board observer for Montara Therapeutics and Abilita Therapeutics. Prior to joining TBC, she was a researcher in the Genetics & Aging research unit of the MassGeneral Institute for Neurodegenerative Disease at Massachusetts General Hospital/Harvard Medical School, working under Dr. Rudy Tanzi developing 3D human neural stem cell models of Alzheimer's disease. She completed her PhD in the Brain & Cognitive Sciences Department at MIT, advised by Dr. Ed Boyden in The McGovern Institute for Brain Research, developing biotechnology platforms for enhanced resolution into clinical samples including brain tissue and liquid biopsies with applications in cancer and neurodegeneration. Her doctoral training was supported by fellowships from the Singleton Foundation and Center for Neurobiological Engineering as well as a Koch Frontiers Award and she served on the teaching team at MIT Sloan School of Management. In her free time, Jenna continues to support MIT entrepreneurs as a Sandbox Innovation Fund Mentor.